Quality Assurance and Regulatory Compliance Office and USAMRIID FDA Risk Management. Carolyn Mentzer Chief, QARCO

Size: px
Start display at page:

Download "Quality Assurance and Regulatory Compliance Office and USAMRIID FDA Risk Management. Carolyn Mentzer Chief, QARCO"

Transcription

1 Quality Assurance and Regulatory Compliance Office and USAMRIID FDA Risk Management Carolyn Mentzer Chief, QARCO

2 Who We Are and What We Do USAMRIID s mission is to conduct basic and applied research on biological threats resulting in medical solutions to protect the warfighter. All medical products administered to warfighters require FDA licensure. FDA ensures that medical products are safe and effective.

3 FDA Quality Management Systems FDA requires safety and efficacy studies conducted in animals and in human clinical trials. GLP - Preclinical safety and animal efficacy studies must comply with 21 CFR 58 Good Laboratory Practice. GCP - Clinical Trials in Humans must adhere to FDA s Good Clinical Practices. GLP/GCP compliant studies are essential to FDA product licensure.

4 GLP and GCP Requirements Quality Assurance (QARCO) oversight Facilities and equipment are demonstrated to be adequate for intended use Controlled SOPs signed by management and followed by study personnel Approved protocols, final reports and documentation adequate to completely reconstruct the study GLP or GCP compliance = reliable data with integrity

5 USAMRIID s Compliance Infrastructure Prevents Mission failure Unsafe or ineffective medical products being administered to soldiers Loss of reputation and funding FDA official actions GLP and GCP compliance mitigates risk.

6 QARCO Mitigates USAMRIID s Regulatory and Public Opinion Risk Auditing clinical and animal studies at all stages of conduct and completion Maintaining USAMRIID s compliance infrastructure including the controlled SOP system Hosting FDA and collaborator capability inspections Managing USAMRIID s computer and equipment validation program QARCO is USAMRIID s risk mitigation department

7 QARCO Quality Assurance An independent and objective tool for management Reports audit findings to USAMRIID Deputy Commander and POCs to assure compliance Tracks issues for management through the corrective action and preventative action, CAPA, system and through periodic status reports Provides training, SOP review and validation activities institute-wide QARCO keeps USAMRIID Command informed and in control.

8 QARCO Staff Regulated, industry-trained and experienced GLP scientific auditors, most with Master s degrees 4/5 are BPRP-enrolled with access to biosafety level BSL-3 and soon BSL-4 suites GCP auditors are registered nurses QARCO staff is highly qualified.

9 QARCO s Document Control Office Manages Regulatory Risk Controlled document management system for 1719 SOP documents that meets regulatory requirements Also complies with DA PAM and requirements Institute-wide accessibility of version-controlled documents via RIID-Vision Controlled SOP administration, periodic review, and training schedule QARCO maintains USAMRIID S SOP system.

10 Glossary 1. BPRP Biological Personnel Reliability Protection program, an Army-mandated program that ensures those personnel with access to Biological Select Agents and Toxins are fit and reliable. 2. BSL Biosafety Level Laboratories that employ engineering and PPE controls to enable laboratorians to work safely with pathogens. BSL-3 and BSL-4 are considered high levels of containment. 3. CAPA Corrective Action and Preventative Action a system that tracks corrective action from discovery to completion. 4. DA Department of Army. 5. DA PAM Department of Army Pamphlet a written guidance provided by the Army to facilitate adherence to DA Regulations. 6. FDA US Food and Drug Administration. 7. FPI Facility / Process Inspections 8. GCP Good Clinical Practice is a robust quality management system required by FDA in greater than minimal risk clinical trials. 9. GLP Good Laboratory Practice, 21 CFR 58, is a robust quality management system required by FDA in nonclinical safety and efficacy studies. 10. ISO International Standards Organization a quality system employed by USAMRIID s Unified Culture Collection laboratory in Diagnostics Systems Division. 11. LATG Laboratory Animal Technologist, a credential bestowed upon highly qualified candidates by the American Association of Laboratory Animal Science. 12. QA Quality Assurance 13. QARCO Quality Assurance and Regulatory Compliance Office. 14. RIID Vision USAMRIID s Intranet. 15. RN Registered Nurse. 16. RQAP Registered Quality Assurance Professional, a credential bestowed upon highly qualified candidates by the US Society of Quality Assurance. 17. SOP Standard Operating Procedures written procedures signed by management adequate to insure the quality and integrity of the data generated in the course of a study.

BIOSECURITY IN THE LABORATORY

BIOSECURITY IN THE LABORATORY BIOSECURITY IN THE LABORATORY Maureen Sullivan Biosecurity Why is biosecurity important History of biosecurity field Definitions Laboratory Biosafety verses Biosecurity Principles and Practice Concepts

More information

Toward Greater Scientific Rigor

Toward Greater Scientific Rigor Toward Greater Scientific Rigor Good Clinical Practice (GCP) A NEW REQUIREMENT! The Center for Clinical & Translational Science 205.934.7442 ccts@uab.edu www.uab.edu/ccts @cctsnetwork The requirement:

More information

NANCI A. HAYWARD North Springs Drive Dunwoody, Georgia

NANCI A. HAYWARD North Springs Drive Dunwoody, Georgia 1595 North Springs Drive Dunwoody, Georgia 30338 404-502-2823 nancihayward@thedragonflysolution.com Summary Over 25 years of team building, goal oriented management, and direct industrial experience using

More information

Solutions for GCP Compliance Challenges. September 23, 2015 Northwestern University IRB Brown Bag Session

Solutions for GCP Compliance Challenges. September 23, 2015 Northwestern University IRB Brown Bag Session Solutions for GCP Compliance Challenges September 23, 2015 Northwestern University IRB Brown Bag Session PAMELA MASON, MPH Vice President, Mason Professional Services, LLC Adjunct Faculty, Northwestern

More information

Solutions for GCP Compliance Challenges

Solutions for GCP Compliance Challenges Solutions for GCP Compliance Challenges September 23, 2015 Northwestern University IRB Brown Bag Session PAMELA MASON, MPH Vice President, Mason Professional Services, LLC Adjunct Faculty, Northwestern

More information

Best Practices for IBCs in Challenging Times

Best Practices for IBCs in Challenging Times Best Practices for IBCs in Challenging Times Betsy Gilman Duane, MS, RBP, CBSP October 21, 2014 Recent Events CDC anthrax incident and influenza shipment FDA discovery of smallpox vials eheinc.com 2 September

More information

Assuring Laboratory Biosecurity

Assuring Laboratory Biosecurity Assuring Laboratory Biosecurity Presentation to The Working Group (WG) on Strengthening the Biosecurity of the United States, Established by Executive Order (EO) 13486, January 9, 2009 Ronald Atlas and

More information

Standard Operating Procedures

Standard Operating Procedures Clinical Monitoring and Site Verification Procedure Overview To define the standard procedures for preparation and documentation of site visits for clinical monitoring and spoke verification for any NETT

More information

Research Audits PGR. Effective: 12/04/2013 Reviewed: 12/04/2015. Name of Associated Policy: Palmetto Health Administrative Research Review

Research Audits PGR. Effective: 12/04/2013 Reviewed: 12/04/2015. Name of Associated Policy: Palmetto Health Administrative Research Review Effective: 12/04/2013 Reviewed: 12/04/2015 Name of Associated Policy: Palmetto Health Administrative Research Review Definitions Responsible Positions Equipment Needed Procedure Steps, Guidelines, Rules,

More information

Computer Validation Initiative Committee Membership Requirements

Computer Validation Initiative Committee Membership Requirements SOP No. CV-02.03 Supersedes SOP No. CV-02.02 Effective Page 1 of 5 Original Issue 18 February 2002 Retirement Computer Validation Initiative Committee Membership Requirements 1. Significant Change(s) from

More information

ONADE s Data Quality Review

ONADE s Data Quality Review ONADE s Data Quality Review Office of New Animal Drug Evaluation Center for Veterinary Medicine Regulatory Affairs in Animal Health Seminar Kansas State University Olathe March 06, 2018 Presenter: Ana

More information

Ryan Burnette, Ph.D. Director, Alliance Biosciences

Ryan Burnette, Ph.D. Director, Alliance Biosciences Ryan Burnette, Ph.D. Director, Alliance Biosciences Global perception of the industry The Offense Existing legislation Legislative update Trans Federal Task Force Biodefense Policy Coordinating Committee

More information

Dr. R. Sathianathan. Role & Responsibilities of Principal Investigators in Clinical Trials. 18 August 2015

Dr. R. Sathianathan. Role & Responsibilities of Principal Investigators in Clinical Trials. 18 August 2015 18 August 2015 Role & Responsibilities of Principal Dr. R. Sathianathan Professor of Psychiatry, SRMC, Porur & Former Director, Institute of Mental Health, Chennai Principal Investigators & GOOD CLINICAL

More information

Training components for GCP. inspectors in PMDA. Tomonori Tateishi, MD, PhD Office of Conformity Audit, PMDA

Training components for GCP. inspectors in PMDA. Tomonori Tateishi, MD, PhD Office of Conformity Audit, PMDA Training components for GCP inspectors in PMDA Tomonori Tateishi, MD, PhD Office of Conformity Audit, PMDA Content 1. Conformity inspection in the training program for newcomers to PMDA 2. The training

More information

NLTC-9. Supporting Your Sentinel Laboratories

NLTC-9. Supporting Your Sentinel Laboratories NLTC-9 Supporting Your Sentinel Laboratories Rob Nickla, BT/CT LRN Coordinator, STC, RO Oregon State Public Health Laboratory Outline Communication & Relationships State Specifics Sentinel Laboratory Site

More information

Clinical Research Professionals

Clinical Research Professionals Training & Resources for Clinical Research Professionals Course & Publications Catalog January July 2016 In-Person and Web-Based Training Courses, Customized Training, elearning and Publications for Clinical

More information

DANA-FARBER / HARVARD CANCER CENTER POLICIES FOR HUMAN SUBJECT RESEARCH TITLE:

DANA-FARBER / HARVARD CANCER CENTER POLICIES FOR HUMAN SUBJECT RESEARCH TITLE: POLICY #: EDU-100 Page: 1 of 5 1. POLICY STATEMENT: Individuals who participate in research activities overseen by DF/HCC must satisfy specific training requirements in order to conduct human subject research.

More information

Introduction to the United States Food and Drug Administration (FDA) and FDA Inspection Process VOICE

Introduction to the United States Food and Drug Administration (FDA) and FDA Inspection Process VOICE Introduction to the United States Food and Drug Administration (FDA) and FDA Inspection Process VOICE 2011 MTN Annual Meeting March 27, 2011 Lisa Noguchi, MSN Donna Germuga, DAIDS, OCSO, RN, BSN Objectives

More information

Postmarketing Drug Safety and Inspection Readiness

Postmarketing Drug Safety and Inspection Readiness Postmarketing Drug Safety and Inspection Readiness June 19, 2018 Center for Drug Evaluation and Research (CDER) Small Business and Industry Assistance (SBIA) Webinar United States Food and Drug Administration

More information

Regulatory Inspections

Regulatory Inspections Regulatory Inspections An Overview of Process, Observations, and Guidance for Investigators Alison Urton, Group Administrator Clive Hansen, Audit Team Leader Outline Regulatory History Health Canada Overview

More information

Study Start-Up SS STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV)

Study Start-Up SS STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV) Replaces previous version 203.01: 01 July 2014 Study Start-Up SS 203.01 STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV) Approval: Nancy Paris, MS, FACHE President and CEO 24 May 2017 (Signature

More information

Department of Defense DIRECTIVE

Department of Defense DIRECTIVE Department of Defense DIRECTIVE NUMBER 5210.88 February 11, 2004 USD(I) SUBJECT: Safeguarding Biological Select Agents and Toxins References: (a) Directive-Type Memorandum, "Safeguarding Biological Select

More information

Quality Assurance in Clinical Research at RM/ICR. GCP Compliance Team, Clinical R&D

Quality Assurance in Clinical Research at RM/ICR. GCP Compliance Team, Clinical R&D Quality Assurance in Clinical Research at RM/ICR GCP Compliance Team, Clinical R&D Slide 1 of 13 What is Quality Assurance? The maintenance of a desired level of quality in a service or product, especially

More information

What is Safety & Compliance? Case Study of a Laboratory Accident Who Sets the Standards for Safety & Compliance Promoting a Culture of Safety Roles

What is Safety & Compliance? Case Study of a Laboratory Accident Who Sets the Standards for Safety & Compliance Promoting a Culture of Safety Roles Department of Environmental Health & Safety EHS Director: Ethan Carter, PhD Email: ethan.carter@ucdenver.edu Website: http://www.ucdenver.edu/ehs Facebook: www.facebook.com/ehsdenver February 6, 2013 What

More information

Biosafety in CDC Laboratories: The Path Forward

Biosafety in CDC Laboratories: The Path Forward Biosafety in CDC Laboratories: The Path Forward Michael W Shaw, PhD Senior Advisor for Laboratory Science Office of Infectious Diseases Department of Health and Human Services Centers for Disease Control

More information

The WHO laboratory network to enhance laboratory biosafety and biosecurity in developing countries

The WHO laboratory network to enhance laboratory biosafety and biosecurity in developing countries World Association of Veterinary Laboratory Diagnosticians 14th International Symposium Madrid, Spain 17-20 June 2009 The WHO laboratory network to enhance laboratory biosafety and biosecurity in developing

More information

TRAINING. A. Hazard Communication/Right-to-Know Training

TRAINING. A. Hazard Communication/Right-to-Know Training XIII. TRAINING A multitude of training requirements are addressed by OSHA and other safety, health and environmental regulations. A summary of these requirements are presented. A. Hazard Communication/Right-to-Know

More information

CDC/APHL Laboratory Biosafety Competencies for the BSL-2, BSL-3 and BSL-4 Laboratories

CDC/APHL Laboratory Biosafety Competencies for the BSL-2, BSL-3 and BSL-4 Laboratories 1. Intro CDC/APHL Laboratory Biosafety Competencies for the BSL-2, BSL-3 and BSL-4 Laboratories CDC and APHL have convened an expert panel to define biosafety competencies for laboratorians working in

More information

GOOD LABORATORY PRACTICES (GLP) OVERVIEW

GOOD LABORATORY PRACTICES (GLP) OVERVIEW GOOD LABORATORY PRACTICES (GLP) OVERVIEW MN ASQ MEETING - 4/11/17 TERRY RICKE COMPLIANCE / AUDIT SPECIALIST MEDTRONIC PHYSIOLOGICAL RESEARCH LABS TERRY.RICKE@MEDTRONIC.COM WHAT IS GLP? Good Laboratory

More information

Audits, Monitoring and Safety Committees

Audits, Monitoring and Safety Committees Audits, Monitoring and Safety Committees Andrew Cannons, Ph.D. Laboratory Director FL Bureau of Public Health Laboratories-Tampa Outline Auditing The Biosafety Program Self Auditing, Internal Auditing,

More information

Effective Date: April 2014 Revision: September 29, Executive Chair, Co-Chairs, NSHA REB Members, REB Office Personnel, Researchers.

Effective Date: April 2014 Revision: September 29, Executive Chair, Co-Chairs, NSHA REB Members, REB Office Personnel, Researchers. TITLE: Standard Operating Procedure (SOP) External Inspections or Audits NUMBER: NSHA REB-SOP-9-002 Effective Date: April 2014 Revision: September 29, 2017 Applies To: Executive Chair, Co-Chairs, NSHA

More information

GCP Inspection by PMDA

GCP Inspection by PMDA 2012 EU GCP Inspectors Working Group Workshop London, 12-14 November 2012 Practical Experience in GCP inspections, non EU/EEA countries GCP Inspection by PMDA Kazuko Natsui Inspector for GCP Inspection,

More information

No Path? No Problem? Perspectives from a Public Health Laboratory

No Path? No Problem? Perspectives from a Public Health Laboratory No Path? No Problem? Perspectives from a Public Health Laboratory Bonnie Rubin, CLS, MBA, MHA Associate Director State Hygienic Laboratory at The University of Iowa Why Biosafety Staffing Is On Our Minds

More information

Safety Culture in Life Sciences Laboratories: Time for Action. Donald R. Callihan

Safety Culture in Life Sciences Laboratories: Time for Action. Donald R. Callihan Safety Culture in Life Sciences Laboratories: Time for Action Donald R. Callihan Safety Culture in Life Sciences Laboratories: Time for Action Discuss personal and cultural safety ethics that support biorisk

More information

Clinical Trial Quality Assurance Common Findings

Clinical Trial Quality Assurance Common Findings Clinical Trial Quality Assurance Common Findings Objectives Identify common findings found in research study reviews conducted by the CTQA Program Understand what findings require an action plan vs. a

More information

INDEPENDENT LEARNER. Course Guide

INDEPENDENT LEARNER. Course Guide INDEPENDENT LEARNER Course Guide CITI Program s independent learner courses are intended to provide access to individuals not affiliated with a subscribing organization or those who have special content

More information

LOUIS STOKES CLEVELAND VA MEDICAL CENTER RESEARCH SERVICE Human Subject Protection Standard Operating Procedure (SOP)

LOUIS STOKES CLEVELAND VA MEDICAL CENTER RESEARCH SERVICE Human Subject Protection Standard Operating Procedure (SOP) LOUIS STOKES CLEVELAND VA MEDICAL CENTER RESEARCH SERVICE Human Subject Protection Standard Operating Procedure (SOP) Effective Date: February 7, 2013 SOP Title: Study Monitoring Visits - Process for Access

More information

An Update on FDA s Good Laboratory Practice (GLP) for Nonclinical Laboratory Studies Proposed Rule

An Update on FDA s Good Laboratory Practice (GLP) for Nonclinical Laboratory Studies Proposed Rule An Update on FDA s Good Laboratory Practice (GLP) for Nonclinical Laboratory Studies Proposed Rule SOT: Regulatory and Safety Evaluation Specialty Section Webinar September 29, 2017 Mark Seaton, Ph.D.,

More information

II. Responsibilities

II. Responsibilities II. Responsibilities The basic safety principle is that all injuries are preventable. Management, from the university President to the Principal Investigator/Supervisor, has a responsibility to encourage

More information

Biological Weapons Convention Meeting of Experts. Geneva, Switzerland August WHO's. Dr Nicoletta Previsani

Biological Weapons Convention Meeting of Experts. Geneva, Switzerland August WHO's. Dr Nicoletta Previsani Biological Weapons Convention Meeting of Experts Geneva, Switzerland 18-22 August 2008 WHO's Biosafety and Laboratory Biosecurity Dr Nicoletta Previsani Biosafety and Laboratory Biosecurity Biorisk Reduction

More information

Policy on Minors in Laboratories

Policy on Minors in Laboratories Policy on Minors in Laboratories Purpose The purpose of this document is to define and clarify the policies pursuant to which minors will be allowed to access and conduct academic research in the laboratories

More information

General Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility

General Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility General Administration GA 102.01 STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility Approval: Nancy Paris, MS, FACHE President and CEO (17 July 2014) (Signature and

More information

World Federation for Culture Collections ICCC-12 Conference Florianopolis, Brazil, 26 Sept 1 Oct Dr Nicoletta Previsani

World Federation for Culture Collections ICCC-12 Conference Florianopolis, Brazil, 26 Sept 1 Oct Dr Nicoletta Previsani World Federation for Culture Collections ICCC-12 Conference 2010 Florianopolis, Brazil, 26 Sept 1 Oct 2010 The Biosafety and Laboratory Biosecurity programme at the World Health Organization Dr Nicoletta

More information

Study Management PP STANDARD OPERATING PROCEDURE FOR Safeguarding Protected Health Information

Study Management PP STANDARD OPERATING PROCEDURE FOR Safeguarding Protected Health Information PP-501.00 SOP For Safeguarding Protected Health Information Effective date of version: 01 April 2012 Study Management PP 501.00 STANDARD OPERATING PROCEDURE FOR Safeguarding Protected Health Information

More information

Biosafety and Exposure Control Plan

Biosafety and Exposure Control Plan California State Polytechnic University, Pomona Biosafety and Exposure Control Plan For Laboratory Research Enter Name of Agents and/or Toxins (Add all agents or toxins that apply.) Leave text formatting

More information

Handbook: Good Laboratory Practice: Quality Practices For Regulated Non-clinical Research And Development By World Health Organization READ ONLINE

Handbook: Good Laboratory Practice: Quality Practices For Regulated Non-clinical Research And Development By World Health Organization READ ONLINE Handbook: Good Laboratory Practice: Quality Practices For Regulated Non-clinical Research And Development By World Health Organization READ ONLINE If you are looking for a ebook by World Health Organization

More information

2016 APHL BIOSAFETY AND BIOSECURITY SURVEY

2016 APHL BIOSAFETY AND BIOSECURITY SURVEY 2014 APHL All Hazards Laboratory Preparedness Survey 2016 APHL BIOSAFETY AND BIOSECURITY SURVEY February 2016 Introduction 2016 APHL Biosafety and Biosecurity Survey Welcome to the 2016 APHL Biosafety

More information

City of Boston Biological Safety Regulations and Laboratory Oversight

City of Boston Biological Safety Regulations and Laboratory Oversight City of Boston Biological Safety Regulations and Laboratory Oversight Julien Farland MS, RBP Director of Biological Safety Boston Public Health Commission February 10, 2014 Outline Introduction to BPHC

More information

BIMO Program Update an operational perspective

BIMO Program Update an operational perspective BIMO Program Update an operational perspective Clinical Trials Summit San Juan, Puerto Rico May 9, 2018 Anne E. Johnson Program Division Director FDA/ORA/OBIMO Division I (East) 1 Objectives Program Alignment

More information

Why do we need an addendum to ICH E6?

Why do we need an addendum to ICH E6? Addendum to ICH E6 Hideaki Ui, Ph.D. Inspection Director Office of Non-clinical and Clinical Compliance Pharmaceuticals and Medical Devices Agency, Japan Disclaimer The views and opinions expressed in

More information

Regulatory,Quality & Emergency Preparedness. MaryBeth Parache Director, Quality Affairs New York Blood Center

Regulatory,Quality & Emergency Preparedness. MaryBeth Parache Director, Quality Affairs New York Blood Center Regulatory,Quality & Emergency Preparedness MaryBeth Parache Director, Quality Affairs New York Blood Center 1 Regulatory 2 Who regulates us? Food and Drug Administration (FDA) Blood, tissue, HCT/P, medical

More information

ANNEX Q HAZARDOUS MATERIALS EMERGENCY RESPONSE

ANNEX Q HAZARDOUS MATERIALS EMERGENCY RESPONSE ANNEX Q HAZARDOUS MATERIALS EMERGENCY RESPONSE PROMULGATION STATEMENT Annex Q: Hazardous Materials Emergency Response, and contents within, is a guide to how the University conducts a response specific

More information

GLOBAL HEALTH SECURITY AGENDA: ACTION PACKAGE PREVENT-3 BIOSAFETY AND BIOSECURITY ASSESSMENT

GLOBAL HEALTH SECURITY AGENDA: ACTION PACKAGE PREVENT-3 BIOSAFETY AND BIOSECURITY ASSESSMENT GLOBAL HEALTH SECURITY AGENDA: ACTION PACKAGE PREVENT-3 BIOSAFETY AND BIOSECURITY ASSESSMENT APP3 Working Group An analysis of biosafety and biosecurity scores for the GHSA External Evaluations and WHO

More information

ICH Regulators Forum. Dr Peter Arlett EU

ICH Regulators Forum. Dr Peter Arlett EU Dr Peter Arlett EU International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use In this presentation ICH Regulators Forum: Background ICH Regulators

More information

Document Title: Study Data SOP (CRFs and Source Data)

Document Title: Study Data SOP (CRFs and Source Data) Document Title: Study Data SOP (CRFs and Source Data) Document Number: SOP047 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D

More information

Post-Doctoral Researcher - Researcher Startup Tool 1 of 8

Post-Doctoral Researcher - Researcher Startup Tool 1 of 8 Post-Doctoral Researcher - Researcher Startup Tool 1 of 8 Mount Sinai Hospital Employees: ITHelpDesk@mountsinai.org 212-241-4357 Sinai Central Account Sinai Central is the system used to manage HR and

More information

Office of the Vice Chancellor for Research Supervisory Responsibilities of Clinical Investigators

Office of the Vice Chancellor for Research Supervisory Responsibilities of Clinical Investigators Office of the Vice Chancellor for Research Supervisory Responsibilities of Clinical Investigators Patricia Fischer, RN, CCRP Investigator Responsibilities FDA Draft Guidance May 2007 Clarifies FDA s expectations,

More information

16 STUDY OVERSIGHT Clinical Quality Management Plans

16 STUDY OVERSIGHT Clinical Quality Management Plans 16 STUDY OVERSIGHT... 1 16.1 Clinical Quality Management Plans... 1 16.2 Site Visits by the LOC, SDMC and LC... 2 16.3 Protocol Team Oversight... 3 16.4 Oversight of Reportable Protocol Deviations... 3

More information

Harrison Clinical Research. Monitoring of Clinical Trials - Quality Management from a CRO s Perspective

Harrison Clinical Research. Monitoring of Clinical Trials - Quality Management from a CRO s Perspective Harrison Clinical Research Monitoring of Clinical Trials - Quality Management from a CRO s Perspective www.harrisonclinical.com 1 17Sep2009 Overview: Monitoring of Clinical Trials 1. Discovering and developing

More information

EMA & FDA Inspections: Site perspective. Shandukani Research Centre

EMA & FDA Inspections: Site perspective. Shandukani Research Centre EMA & FDA Inspections: Site perspective Shandukani Research Centre Why were we inspected? Pharmaceutical company applied for registration of the study drug (Phase I/II dosing studies in paediatrics) Large

More information

Iraq Biological Security Grant Competition Project Proposal

Iraq Biological Security Grant Competition Project Proposal Iraq Biological Security Grant Competition Project Proposal P a g e 1 A. GENERAL PROJECT INFORMATION PROJECT INFORMATION Project Title (Not more than 100 characters) Total Amount Requested ($20,000 min.

More information

50 Years of Ethical Human Subjects Research at Fort Detrick By Caree Vander Linden edited by Arthur O. Anderson, USAMRIID

50 Years of Ethical Human Subjects Research at Fort Detrick By Caree Vander Linden edited by Arthur O. Anderson, USAMRIID 50 Years of Ethical Human Subjects Research at Fort Detrick By Caree Vander Linden edited by Arthur O. Anderson, USAMRIID On 27 January 2005, the U.S. Army Medical Research Institute of Infectious Diseases

More information

managing or activities.

managing or activities. STANDARD OPERATING PROCEDURE Clinical Research Monitoring TITLE: Site Initiation Visit TITLE: Site Initiation Visit 1. PURPOSE SOP Number: Version: 1.0 MICHR CRM MON 002 Effective Date: 19Dec2013 1.1 This

More information

Principal Investigator/Co-Investigator - Researcher Startup Tool 1 of 9

Principal Investigator/Co-Investigator - Researcher Startup Tool 1 of 9 Principal Investigator/Co-Investigator - Researcher Startup Tool 1 of 9 Mount Sinai Hospital Employees: ITHelpDesk@mountsinai.org 212-241-4357 Sinai Central Account Sinai Central is the system used to

More information

FOOD AND DRUG ADMINISTRATION COMPLIANCE PROGRAM GUIDANCE MANUAL PROGRAM

FOOD AND DRUG ADMINISTRATION COMPLIANCE PROGRAM GUIDANCE MANUAL PROGRAM FOOD AND DRUG ADMINISTRATION COMPLIANCE PROGRAM GUIDANCE MANUAL PROGRAM 7348.810 CHAPTER 48 Bioresearch Monitoring SUBJECT: SPONSORS, CONTRACT RESEARCH ORGANIZATIONS AND MONITORS REVISION: IMPLEMENTATION

More information

FDA Inspectional Process in Clinical Research An FDA Perspective. Annette Melendez, MPHsN Investigator Office of Biological Products Operations

FDA Inspectional Process in Clinical Research An FDA Perspective. Annette Melendez, MPHsN Investigator Office of Biological Products Operations FDA Inspectional Process in Clinical Research An FDA Perspective Annette Melendez, MPHsN Investigator Office of Biological Products Operations Outline BIMO PROGRAM OVERVIEW PROGRAM COVERED AREAS INSPECTIONAL

More information

Vertex Investigator-Initiated Studies Program Overview

Vertex Investigator-Initiated Studies Program Overview Vertex Investigator-Initiated Studies Program Overview Our Goal Our Investigator Initiated Study grants support independent, investigator-initiated research designed to advance scientific knowledge of

More information

SAINT LOUIS UNIVERSITY

SAINT LOUIS UNIVERSITY SAINT LOUIS UNIVERSITY Occupational Health Program for Laboratory and Animal Research Policy Number: RC-006 Version Number: 1.0 Classification: Research Compliance Effective Date: 05DEC2011 Responsible

More information

Investigator Roles and Responsibilities in Clinical Device Trials

Investigator Roles and Responsibilities in Clinical Device Trials Investigator Roles and Responsibilities in Clinical Device Trials A Total Product Lifecycle Approach to Medical Device Development: Responsibilities and Opportunities The Stanford Center for Clinical and

More information

STANDARD OPERATING PROCEDURE

STANDARD OPERATING PROCEDURE STANDARD OPERATING PROCEDURE Title Reference Number Corrective and Preventative Action SOP-QMS-008 Version Number 2 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s)

More information

Document Title: Informed Consent for Research Studies

Document Title: Informed Consent for Research Studies Document Title: Informed Consent for Research Studies Document Number: SOP003 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D

More information

Administrative Burden of Research Compliance

Administrative Burden of Research Compliance Administrative Burden of Research Compliance Measuring and Minimizing David L. Wynes, Ph.D. Vice President for Research Administration Emory University 1 FDP Faculty Burden Survey (X2) PIs estimated that

More information

Occupational Health and Medical Surveillance Program at NBACC

Occupational Health and Medical Surveillance Program at NBACC Occupational Health and Medical Surveillance Program at NBACC American Biological Safety Association Conference Kansas City, Missouri TM 23 October 2013 The NBACC logo is the intellectual property of DHS.

More information

12.0 Investigator Responsibilities

12.0 Investigator Responsibilities 12.0 Investigator Responsibilities 12.1 Policy Investigators are ultimately responsible for the conduct of research. Research must be conducted according to the signed Investigator statement, the investigational

More information

SOP-QA-28 V2. Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School

SOP-QA-28 V2. Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School Title: Effective Date: 1-4-17 Review Date: 1-4-20 Author: Richard Cowie, QA Manager QA Approval: Richard Cowie, QA Manager Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head

More information

Good Clinical Practice: A Ground Level View

Good Clinical Practice: A Ground Level View Good Clinical Practice: A Ground Level View Jeanna Julo, BA, BA, CCRP Assistant Director, Clinical Data Management & Quality Controls, Auditing & Training Clinical Research Administration Research Institute,

More information

The Clinical Research Center Research Practice Manual. Guideline for Study Document and Data Handling RPG-08. Guideline. Purpose.

The Clinical Research Center Research Practice Manual. Guideline for Study Document and Data Handling RPG-08. Guideline. Purpose. The Clinical Research Center Research Practice Manual Guideline for Study Document and Data Handling RPG-08 Purpose Guideline This Guideline provides functional definitions for common data management terms;

More information

Good Documentation Practices. Human Subject Research. for

Good Documentation Practices. Human Subject Research. for Good Documentation Practices for Human Subject Research Bridget M. Psicihulis, RHIA, CCRC Quality Improvement Unit Coordinator Human Research Protection Program Wheaton Franciscan Healthcare (last updated

More information

WHO Laboratory Biosafety Manual Revision

WHO Laboratory Biosafety Manual Revision WHO Laboratory Biosafety Manual Revision 02 February 2016, CDC Symposium Dr Kazunobu KOJIMA WHO Headquarters, Geneva WHO Laboratory Biosafety Manual Having served for global biosafety community Hereinafter,

More information

Human Pathogens and Toxins Act: Bill C-11

Human Pathogens and Toxins Act: Bill C-11 1 Human Pathogens and Toxins Act: Bill C-11 2 Gaps of the Current Regulatory Regime The Human Pathogens Importation Regulations (HPIR) were established in 1994 to provide mandatory oversight for only imported

More information

Margaret Huber, RN, CHRC Compliance Consultant Office of Research Compliance

Margaret Huber, RN, CHRC Compliance Consultant Office of Research Compliance Margaret Huber, RN, CHRC Compliance Consultant Office of Research Compliance 4/20/2015 Objectives Define monitoring and explain why monitoring is important in clinical trials Provide an overview of the

More information

Office of Human Research Ethics/IRB Standard Operating Procedures

Office of Human Research Ethics/IRB Standard Operating Procedures Office of Human Research Ethics/IRB Standard Operating Procedures Effective June 2, 2017 TABLE OF CONTENTS Office of Human Research Ethics/IRB Standard Operating Procedures 101 UNC-Chapel Hill Human Research

More information

MHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager

MHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager MHRA Findings Dissemination Joint Office Launch Jan. 2012 Presented by: Carolyn Maloney UHL R&D Manager Purpose of presentation To feed back abridged findings from March 2011 MHRA Statutory Systems Inspection

More information

The Critical Reagents Program s Quality Initiatives. Critical Reagents Program (CRP)

The Critical Reagents Program s Quality Initiatives. Critical Reagents Program (CRP) Our Vision is to protect the Warfighter by maintaining uncontested global supremacy in CBRN medical countermeasure development and delivery. DRAFT The Critical Reagents Program s Quality Initiatives February

More information

Clinical Research Seminar

Clinical Research Seminar Clinical Research Seminar HOW TO DEVELOP A CORRECTIVE AND PREVENTIVE ACTION PLAN (THAT EVEN THE IRB AND FDA WILL LOVE) April 11, 2018 Fiona Rice, MPH Human Research Quality Manager fionar@bu.edu Mary-Tara

More information

STANDARD OPERATING PROCEDURE SOP 715. Principles of Clinical Research Laboratory Practice

STANDARD OPERATING PROCEDURE SOP 715. Principles of Clinical Research Laboratory Practice STANDARD OPERATING PROCEDURE SOP 715 Principles of Clinical Research Laboratory Practice Version 1.2 Version date 13.11.2015 Effective date 24.04.2017 Number of pages 9 Review date June 2018 Author Role

More information

POINT Trial Organization

POINT Trial Organization 3.0 STUDY ORGANIZATION The POINT study is a collaboration of established research networks connected through the leadership of the Principal investigators. Day to day operational oversight is provided

More information

Overview ICH GCP E6(R2) Integrated Addendum

Overview ICH GCP E6(R2) Integrated Addendum 2017 Biomedical Research Alliance of New York LLC CITI Program is a division of BRANY Overview ICH GCP E6(R2) Integrated Addendum Introduction On 15 December 2016, the International Council for Harmonistion

More information

Research Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004

Research Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004 Title: Outcome Statement: Research Auditing and Monitoring Procedures Researchers in the Trust and research partners will be informed about the requirements and procedures involved in research audit and

More information

BOSTON PUBLIC HEALTH COMMISSION REGULATION BIOLOGICAL LABORATORY REGULATIONS

BOSTON PUBLIC HEALTH COMMISSION REGULATION BIOLOGICAL LABORATORY REGULATIONS BOSTON PUBLIC HEALTH COMMISSION REGULATION BIOLOGICAL LABORATORY REGULATIONS Adopted September 19, 2006 SECTION 1.00 DEFINITIONS a. "Abutting community", a city, town or neighborhood contiguous to or touching

More information

QUALITY & REGULATORY APPRENTICESHIP PROGRAM

QUALITY & REGULATORY APPRENTICESHIP PROGRAM QUALITY & REGULATORY APPRENTICESHIP PROGRAM Authorized Apprenticeship Sponsor Learning Partners Registered Apprentice Host Company Quality Assurance Associate GXP Auditor Drug Safety Associate Clinical

More information

FDA Medical Device Regulations vs. ISO 14155

FDA Medical Device Regulations vs. ISO 14155 Vol. 11, No. 9, September 2015 Happy Trials to You FDA Medical Device Regulations vs. ISO 14155 By Shawn Kennedy Medical device clinical trials must comply with 21 CFR Parts 11 (Electronic Records), 50

More information

STANDARD OPERATING PROCEDURE

STANDARD OPERATING PROCEDURE STANDARD OPERATING PROCEDURE Title Reference Number Study Management and Handover SOP-RES-012 Version Number 3 Issue Date 19 th April 2017 Effective Date 2 nd June 2017 Review Date 2 nd June 2019 Author(s)

More information

HIC Standard Operating Procedure. For-Cause Audits of Human Research Studies

HIC Standard Operating Procedure. For-Cause Audits of Human Research Studies HIC Standard Operating Procedure For-Cause Audits of Human Research Studies Background As part of the Wayne State University (WSU) Human Investigation Committee s (HIC) Human Research Protection Program,

More information

The Implementation of Biorisk compliance with International Standard

The Implementation of Biorisk compliance with International Standard The Implementation of Biorisk compliance with International Standard Presentation to Regional Seminar for OIE National Focal Points for Veterinary Laboratories Jeju, RO Korea, 5-7 April 2016 Indrawati

More information

Tomoko OSAWA, Ph.D. Director for GCP Inspection Office of Conformity Audit PMDA, Japan

Tomoko OSAWA, Ph.D. Director for GCP Inspection Office of Conformity Audit PMDA, Japan Tomoko OSAWA, Ph.D. Director for GCP Inspection Office of Conformity Audit PMDA, Japan The views presented in this presentation are those of the author and should not be understood or quoted as being made

More information

General Administration GA STANDARD OPERATING PROCEDURE FOR Document Development and Change Control

General Administration GA STANDARD OPERATING PROCEDURE FOR Document Development and Change Control General Administration GA 104.00 STANDARD OPERATING PROCEDURE FOR Document Development and Change Control Approval: Nancy Paris, MS, FACHE President and CEO 08 March 2012 (Signature and Date) Approval:

More information

2 WHO: World Health Organization 3 ISO: International Organization for Standardization

2 WHO: World Health Organization 3 ISO: International Organization for Standardization Reliable laboratory services can be delivered only by specialised facilities that are appropriately constructed and managed to provide the operating environment where the complex interaction of qualified

More information

Setting up a CITI account for users not enrolled at or employed by Georgia Tech. Georgia Institute of Technology December 2016

Setting up a CITI account for users not enrolled at or employed by Georgia Tech. Georgia Institute of Technology December 2016 Setting up a CITI account for users not enrolled at or employed by Georgia Tech Georgia Institute of Technology December 2016 www.citiprogam.org Select REGISTER to establish an account. Affiliate with

More information

Good Clinical Practice. Lisa de Blieck MPA CCRC Clinical Trials Coordination Center

Good Clinical Practice. Lisa de Blieck MPA CCRC Clinical Trials Coordination Center Good Clinical Practice Lisa de Blieck MPA CCRC Clinical Trials Coordination Center Good Clinical Practice (GCP) An international standard for the design, conduct, performance, monitoring, auditing, recording,

More information